Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel

Circulation Research
A A WildeM J Janse

Abstract

We investigated the contribution of opening of the ATP-sensitive K+ channel to extracellular accumulation of K+ during ischemia with the use of glibenclamide, a specific blocker of this K+ channel. To characterize the electrophysiological effects of glibenclamide during metabolic inhibition (by either application of dinitrophenol or hypoxia) we performed patch-clamp studies in isolated membrane patches of guinea pig myocytes and in intact guinea pig myocytes and studied action potential parameters in isolated superfused guinea pig papillary muscle. We studied the effect of glibenclamide on extracellular accumulation of K+ and H+ in isolated retrogradely perfused globally ischemic hearts of rat, guinea pig, and rabbit. Experimental evidence is presented that supports the conclusions that glibenclamide 1) effectively blocks open K+ATP channels, 2) reverses the dinitrophenol-induced increase of the outward current and prevents the hypoxia-induced shortening of the action potential, 3) decreases the rate of K+ accumulation during the first minutes of ischemia in stimulated hearts, an effect which was entirely absent in quiescent hearts, and 4) does not influence the rate and extent of ischemia-induced extracellular acidification.

References

Jul 15, 1987·Biochemical and Biophysical Research Communications·H Schmid-AntomarchiM Lazdunski
Oct 1, 1987·Journal of Molecular and Cellular Cardiology·A G KléberM J Janse
Jan 1, 1988·The Journal of Membrane Biology·I Findlay
Jul 29, 1988·Biochemical and Biophysical Research Communications·D EscandeI Cavero
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M C SanguinettiP K Siegl
Aug 1, 1989·Journal of Molecular and Cellular Cardiology·C D WollebenP K Siegl
Jan 1, 1989·Pflügers Archiv : European journal of physiology·A A WildeJ W Fiolet
Sep 1, 1989·Pflügers Archiv : European journal of physiology·D EscandeI Cavero
Nov 1, 1989·The Journal of General Physiology·J N Weiss, S T Lamp
Oct 1, 1988·Journal of Molecular and Cellular Cardiology·A A WildeM J Janse
Jul 1, 1988·Pflügers Archiv : European journal of physiology·I Findlay
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M D SternE G Lakatta
Apr 1, 1986·Journal of Molecular and Cellular Cardiology·M J JanseF Wilms-Schopman
Apr 1, 1986·Journal of Molecular and Cellular Cardiology·A GaspardoneP A Poole-Wilson
Jan 1, 1974·Annual Review of Medicine·G S LeveyR F Palmer
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
May 1, 1984·Journal of Molecular and Cellular Cardiology·A G Kléber
Oct 1, 1980·Circulation Research·A VleugelsE Carmeliet
Feb 1, 1968·The Journal of Clinical Investigation·A M WeisslerJ K Gallimore

❮ Previous
Next ❯

Citations

Dec 7, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·V V KupriyanovR Deslauriers
Jul 1, 1992·Clinical Cardiology·T MaedaR Takaki
Nov 1, 1992·Medicinal Research Reviews·K S Atwal
Oct 15, 1998·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·N B RadfordA D Sherry
Jun 1, 1992·Cardiovascular Drugs and Therapy·W A Coetzee
Aug 1, 1993·Cardiovascular Drugs and Therapy·J N Weiss, N Venkatesh
Aug 1, 1993·Cardiovascular Drugs and Therapy·L H Opie
Aug 1, 1993·Cardiovascular Drugs and Therapy·A A Wilde
Feb 17, 1993·Molecular and Cellular Biochemistry·L VirágM Hiraoka
Jul 1, 1992·Trends in Pharmacological Sciences·D Escande, I Cavero
Jul 1, 1996·Diabetes Research and Clinical Practice·A Végh, J G Papp
May 1, 1994·General Pharmacology·G FroldiG Fassina
Jul 1, 1993·Trends in Cardiovascular Medicine·R S Kass, L C Freeman
Aug 26, 2000·European Journal of Pharmacology·W A CoetzeeM Avkiran
May 12, 2001·European Journal of Pharmacology·A J WorkmanB J Northover
Jan 10, 2002·European Journal of Pharmacology·Ryuichi SatoTaku Nagao
Apr 4, 1997·European Journal of Pharmacology·A FukunariT Nakajima
Aug 26, 1998·European Journal of Pharmacology·R NiwaJ Toyama
Aug 10, 1999·European Journal of Pharmacology·T TangA K Ho
Dec 2, 1999·Journal of the Autonomic Nervous System·C E SearsD J Paterson
Nov 10, 1998·Clinical and Experimental Pharmacology & Physiology·L B TankóH Gregersen
Aug 1, 1992·British Journal of Pharmacology·E Ruiz PetrichO F Schanne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.